Catheter Precision Statistics
Total Valuation
VTAK has a market cap or net worth of $2.64 million. The enterprise value is $3.27 million.
Important Dates
The last earnings date was Wednesday, November 13, 2024, after market close.
| Earnings Date | Nov 13, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
VTAK has 8.00 million shares outstanding. The number of shares has increased by 149.84% in one year.
| Current Share Class | 8.00M |
| Shares Outstanding | 8.00M |
| Shares Change (YoY) | +149.84% |
| Shares Change (QoQ) | +170.81% |
| Owned by Insiders (%) | 6.36% |
| Owned by Institutions (%) | 7.85% |
| Float | 6.21M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.88 |
| Forward PS | 1.10 |
| PB Ratio | 0.09 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 8.20 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.66, with a Debt / Equity ratio of 0.15.
| Current Ratio | 0.66 |
| Quick Ratio | 0.53 |
| Debt / Equity | 0.15 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -490.41 |
Financial Efficiency
Return on equity (ROE) is -67.36% and return on invested capital (ROIC) is -36.64%.
| Return on Equity (ROE) | -67.36% |
| Return on Assets (ROA) | -22.62% |
| Return on Capital (ROIC) | -36.64% |
| Revenue Per Employee | $28,500 |
| Profits Per Employee | -$834,571 |
| Employee Count | 14 |
| Asset Turnover | 0.01 |
| Inventory Turnover | 0.79 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -92.50% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -92.50% |
| 50-Day Moving Average | 0.47 |
| 200-Day Moving Average | 2.75 |
| Relative Strength Index (RSI) | 34.95 |
| Average Volume (20 Days) | 152,401 |
Short Selling Information
The latest short interest is 183,675, so 2.29% of the outstanding shares have been sold short.
| Short Interest | 183,675 |
| Short Previous Month | 46,547 |
| Short % of Shares Out | 2.29% |
| Short % of Float | 2.96% |
| Short Ratio (days to cover) | 0.02 |
Income Statement
In the last 12 months, VTAK had revenue of $399,000 and -$11.68 million in losses. Loss per share was -$10.96.
| Revenue | 399,000 |
| Gross Profit | 361,000 |
| Operating Income | -10.79M |
| Pretax Income | -6.85M |
| Net Income | -11.68M |
| EBITDA | -8.69M |
| EBIT | -10.79M |
| Loss Per Share | -$10.96 |
Full Income StatementBalance Sheet
The company has $1.27 million in cash and $1.90 million in debt, giving a net cash position of -$632,000 or -$0.08 per share.
| Cash & Cash Equivalents | 1.27M |
| Total Debt | 1.90M |
| Net Cash | -632,000 |
| Net Cash Per Share | -$0.08 |
| Equity (Book Value) | 12.83M |
| Book Value Per Share | 3.71 |
| Working Capital | -872,000 |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$8.30 million and capital expenditures -$85,000, giving a free cash flow of -$8.38 million.
| Operating Cash Flow | -8.30M |
| Capital Expenditures | -85,000 |
| Free Cash Flow | -8.38M |
| FCF Per Share | -$1.05 |
Full Cash Flow StatementMargins
| Gross Margin | 90.48% |
| Operating Margin | -2,704.01% |
| Pretax Margin | -2,928.32% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |